BTS
FLXN

BB&T Securities’s Flexion Therapeutics, Inc. FLXN Stock Holding History

BB&T Securities’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19,000
Closed -$425K – 1612
2018
Q1 		$425K Hold
19,000
– – ﹤0.01% 1092
2017
Q4 		$475K Buy
+19,000
New +$465K 0.01% 1016

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BB&T Securities's FLXN Position: Q3 2019 in Review

BB&T Securities held its Flexion Therapeutics, Inc. (FLXN) position steady in Q3 2019 at 25,700 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #1251.

BB&T Securities first reported a position in FLXN in Q2 2017 and has held it in 10 quarters since. The position peaked at $705K in Q2 2018. 126 funds tracked by Wall St. Rank hold FLXN as of Q3 2019.

  • BB&T Securities held 25,700 shares of Flexion Therapeutics, Inc. worth $352K as of Q3 2019.
  • BB&T Securities left its Flexion Therapeutics, Inc. share count unchanged in Q3 2019.
  • Flexion Therapeutics, Inc. made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1251 holding.
  • BB&T Securities first reported a position in Flexion Therapeutics, Inc. in Q2 2017 and has held it in 10 quarters since.
  • BB&T Securities's Flexion Therapeutics, Inc. position peaked at $705K in Q2 2018.
  • 126 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.